1. Home
  2. Live Updates
  3. Astrazeneca news

Live Breaking News & Updates on Astrazeneca news

Stay informed with the latest breaking news from Astrazeneca news on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Astrazeneca news and stay connected to the pulse of your community

AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants

Cambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by...

Nagasaki , Yamagata , Japan , China , Japanese , Hiroyuki-moriuchi , Iskra-reic , Astrazeneca , European-union , Japanese-ministry-of-health , Nagasaki-university-graduate-school-of-biomedical-sciences , Head-of-department-pediatrics

AstraZeneca gets global online STARMAP license from Nanoform Finland

Helsinki: Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company has announced that it has granted AstraZeneca Plc a global online STARMAP license. STARMAP is a digital AI version...

Astrazeneca , Nanoform-finland , Astrazeneca-news , Christian-jones , Starmap ,

AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia

Cambridge: AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic...

Japan , China , Chinese , Dave-fredrickson , Li-jianyong , National-medical-products-administration , Astrazeneca , Jiangsu-province , Executive-vice-president , Oncology-business-unit , Astrazeneca-news , Calquence

AstraZeneca Soliris approved in Japan for paediatric patients with generalised myasthenia gravis

Cambridge: AstraZeneca's Soliris (eculizumab) has been approved in Japan for expanded use to include the treatment of generalised myasthenia gravis (gMG) in paediatric patients who are...

Tokyo , Japan , China , Japanese , Keiko-ishigaki , Marc-dunoyer , School-of-medicine , Department-of-pediatrics , Tokyo-women-medical-university , Japanese-ministry-of-health , European-union , Japanese-ministry

AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer

Cambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of adult patients with BRCA-mutated (BRCAm)...

Japan , Japanese , Mototsugu-oya , Dave-fredrickson , Eliav-barr , Keio-university-school-of-medicine , Head-of-global-clinical-development , Japanese-ministry-of-health , Astrazeneca , Research-laboratories , Department-of-urology , European-union

AstraZeneca Koselugo gets Chinese nod for paediatric patients with neurofibromatosis type 1, plexiform neurofibromas

In addition to China, Koselugo is also approved in the US, EU, Japan and several other countries for the treatment of paediatric patients with NF1 and symptomatic, inoperable PNs.

China , Jiaotong , Guizhou , Japan , Shanghai , Marc-dunoyer , Li-qingfeng , Jiaotong-university-school-of-medicine , National-medical-products-administration , Department-of-plastic , National-institutes-of-health-cancer-institute , Cancer-therapy-evaluation-program

AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia

Calquence (acalabrutinib) is a next-generation, selective inhibitor of BTK.

Japan , Tokyo , Japanese , Dave-fredrickson , Koji-izutsu , National-cancer-center-hospital , Astrazeneca , Department-head , Japanese-ministry-of-health , Department-of-hematology , Japanese-ministry , East-asia

AstraZeneca to buy Neogene Therapeutics for over Rs 2605 crore

Neogene will operate as a wholly owned subsidiary of AstraZeneca, with operations in Amsterdam, the Netherlands and California, US.

California , United-states , Netherlands , Amsterdam , Noord-holland , Carsten-linnemann , Susan-galbraith , Astrazeneca , Executive-vice-president , Chief-executive-officer , Astrazeneca-news , Neogene-therapeutics

AstraZeneca severe asthma treatment Tezspire gets Japanese nod

UK: AstraZeneca has announced that Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or refractory disease in whom asthma symptoms cannot...

Japan , Tokyo , Japanese , Hironori-sagara , Astrazeneca , Showa-university-school-of-medicine , Japanese-ministry-of-health , Japanese-ministry , Medicine-division , Respiratory-medicine , Showa-university-school , Executive-vice-president

AstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis

Ultomiris (ravulizumab), the first and only long-acting C5 complement inhibitor, offers immediate, complete and sustained complement inhibition.

Italy , Japan , Milan , Lombardia , Istituto-neurologico-carlo-besta , Marc-dunoyer , Renato-mantegazza , Committee-for-medicinal-products-human , Department-of-neuroimmunology , European-commission , Medicinal-products , Human-use